JNJ.DE

Johnson & Johnson | Cotação de Ações

Última atualização08/08/2025, 12:35:59

Preço€ 148,52

Variação (dia)€ 2,26 (1.54%)▲

Min. 52 Semanas€ 128,16

Máx. 52 Semanas€ 161,30

Capitalização de mercado--

Endereço: One Johnson & Johnson Plaza, New Brunswick, NJ, 08933

Telefone: 732 524 0400

Funcionários: 138.100

JOHNSON & JOHNSON RJNJ.DE

€ 148,52

+ 2,261,5%

08/08/2025 12:35:59

1D 7D 1M 3M 1A Tudo

Visão geral da empresa

Preço atual€ 148,52

Valor de mercado--

Abertura€ 144,78

Preço máximo€ 148,52

Preço mínimo€ 146,70

Volume€ 1,1 mil

Fechamento anterior€ 146,26

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; circulatory restoration products for the treatment of calcified coronary artery and peripheral artery diseases; and neurovascular care that treats hemorrhagic and ischemic stroke. This segment offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Ações relacionadas

The Coca-Cola Company

CCC3.DE ▼0.67% | € 58,68

The Procter & Gamble Company

PRG.DE ▼2.68% | € 156,04

Microsoft Corporation

MSF.DE ▼1.85% | € 424,30

McDonald's Corporation

MDO.DE ▼0.60% | € 271,30

Visa Inc.

3V64.DE ▲1.70% | € 314,75

Assine nossa newsletter para receber atualizações gratuitas por e-mail

Mantenha-se informado assinando nossa newsletter. Receba atualizações gratuitas por e-mail, incluindo rendimentos, novidades do mercado e insights valiosos. Estamos comprometidos em fornecer informações relevantes diretamente à sua caixa de entrada.

Saiba mais sobre a brapi e nossa missão de fornecer informações confiáveis

Entenda a missão da brapi em fornecer informações estritamente informativas de fontes confiáveis. Valorizamos a transparência e a responsabilidade, incentivando investidores a buscar aconselhamento financeiro independente para decisões informadas.

Acesse a Documentação para uma compreensão detalhada da nossa plataforma

Explore a Documentação para uma compreensão detalhada de como utilizar efetivamente nossa plataforma para análise de investimentos. Oferecemos recursos abrangentes para orientar investidores, desde iniciantes até experientes, na navegação por nossa plataforma.